BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swardfager W, Yang P, Herrmann N, Lanctôt KL, Shah BR, Kiss A, Oh PI. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes. Diabet Med 2016;33:529-36. [PMID: 26220364 DOI: 10.1111/dme.12872] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Larowe LR, Bohlen LC, Gaudiano BA, Abrantes AM, Butryn ML, Dunsiger SI, Griffin E, Loucks EB, Uebelacker LA, Williams DM. Testing the feasibility and acceptability of an Acceptance and Commitment Therapy intervention to increase physical activity among individuals with depression: A protocol paper. Mental Health and Physical Activity 2022;23:100475. [DOI: 10.1016/j.mhpa.2022.100475] [Reference Citation Analysis]
2 Abrantes AM, Garnaat SL, Stein MD, Uebelacker LA, Williams DM, Carpenter LL, Greenberg BD, Desaulniers J, Audet D. A pilot randomized clinical trial of tDCS for increasing exercise engagement in individuals with elevated depressive symptoms: Rationale, design, and baseline characteristics. Contemp Clin Trials Commun 2022;29:100972. [PMID: 36092972 DOI: 10.1016/j.conctc.2022.100972] [Reference Citation Analysis]
3 Bendau A, Petzold M, Ströhle A. Bewegung, körperliche Aktivität und Sport bei depressiven Erkrankungen. NeuroTransmitter 2022;33:52-61. [DOI: 10.1007/s15016-021-9343-y] [Reference Citation Analysis]
4 Molsted S, Jensen TM, Larsen JS, Olesen LB, Eriksen SBM, Rehling T, Rasmussen SS, Aadahl M, Cherubini V. Changes of Physical Function and Quality of Life in Patients with Type 2 Diabetes after Exercise Training in a Municipality or a Hospital Setting. Journal of Diabetes Research 2022;2022:1-6. [DOI: 10.1155/2022/5751891] [Reference Citation Analysis]
5 Wu CY, Cogo-Moreira H, MacIntosh BJ, Edwards JD, Krance SH, Eid M, Schreiner PJ, Launer LJ, Swardfager W. Dynamic relationships between depressive symptoms and insulin resistance over 20 years of adulthood. Psychol Med 2021;53:1-10. [PMID: 36470626 DOI: 10.1017/S0033291721003032] [Reference Citation Analysis]
6 Ouk M, Wu C, Colby-milley J, Fang J, Zhou L, Shah BR, Herrmann N, Lanctôt KL, Linkewich E, Law M, Swartz RH, Kapral MK, Black SE, Macintosh BJ, Edwards JD, Swardfager W. Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke. Stroke 2020;51:3531-40. [DOI: 10.1161/strokeaha.120.031068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Castellon-Lopez Y, Skrine Jeffers K, Duru OK, Moreno G, Moin T, Grotts J, Mangione CM, Norris KC, Hays RD. Psychometric Properties of the Altarum Consumer Engagement (ACE) Measure of Activation in Patients with Prediabetes. J Gen Intern Med 2020;35:3159-65. [PMID: 32162203 DOI: 10.1007/s11606-020-05727-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Choi NG, Sullivan JE, DiNitto DM, Kunik ME. Associations between psychological distress and health-related behaviors among adults with chronic kidney disease. Prev Med 2019;126:105749. [PMID: 31199950 DOI: 10.1016/j.ypmed.2019.06.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis. Qual Life Res 2019;28:1413-27. [PMID: 30565072 DOI: 10.1007/s11136-018-2082-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 9.6] [Reference Citation Analysis]
10 Darwish L, Beroncal E, Sison MV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obes 2018;11:333-43. [PMID: 30022843 DOI: 10.2147/DMSO.S106797] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 9.8] [Reference Citation Analysis]
11 Wilson C, Twigg G. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population. Journal of the American Pharmacists Association 2018;58:205-9. [DOI: 10.1016/j.japh.2017.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
12 Atlantis E, Ghassem Pour S, Girosi F. Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study. BMJ Open 2018;8:e018255. [PMID: 29362254 DOI: 10.1136/bmjopen-2017-018255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Coates V, Slevin M, Carey M, Slater P, Davies M. Declining structured diabetes education in those with type 2 diabetes: A plethora of individual and organisational reasons. Patient Educ Couns 2018;101:696-702. [PMID: 29103881 DOI: 10.1016/j.pec.2017.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Carter J, Cogo-Moreira H, Herrmann N, Merino D, Yang P, Shah BR, Kiss A, Reitav J, Oh PI, Swardfager W. Validity of the Center for Epidemiological Studies Depression scale in Type 2 diabetes. J Psychosom Res 2016;90:91-7. [PMID: 27772565 DOI: 10.1016/j.jpsychores.2016.09.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
15 Carter J, Swardfager W. Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes. Psychoneuroendocrinology 2016;69:123-32. [PMID: 27088371 DOI: 10.1016/j.psyneuen.2016.04.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]